US Broker Ratings

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 563% Upside with Innovative Cancer Therapies

Cel-Sci Corporation (NYSE: CVM), a clinical-stage biotechnology company, is capturing investor attention with its innovative approach to treating cancer through immunotherapy. Despite its modest market capitalization of $53.9 million, the..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 36% Potential Upside in the Diagnostics Sector

As an investor navigating the healthcare sector’s complex landscape, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a compelling opportunity with a potential upside of 36.05%. Specializing in molecular diagnostic testing and..

Septerna, Inc. (SEPN) Stock Analysis: Exploring a 26.95% Potential Upside in Biotechnology

Septerna, Inc. (NASDAQ: SEPN) stands at the forefront of the biotechnology sector, captivating investor interest with a compelling 26.95% potential upside based on its current market dynamics. Headquartered in South..

Keros Therapeutics, Inc. (KROS) Investor Outlook: Exploring a Promising 20.76% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is catching the eye of investors with its impressive potential upside and groundbreaking therapeutic developments. With a market capitalization of $592.87..

Humacyte, Inc. (HUMA) Stock Analysis: Biotechnology Innovator with a Potential 588.78% Upside

Humacyte, Inc. (HUMA), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to developing bioengineered human tissues. Headquartered in Durham, North Carolina, Humacyte stands out..

Auna SA (AUNA): Healthcare Stock with Nearly 55% Upside Potential – Investor Outlook

Auna SA (AUNA), a prominent player in the healthcare sector, is garnering significant attention from investors due to its potential for substantial upside. With a market capitalization of $418.91 million,..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 155% Potential Upside in the Telehealth Sector

LifeMD, Inc. (NASDAQ: LFMD) is capturing attention in the healthcare sector with its unique direct-to-patient telehealth services, boasting a market cap of $174.25 million. As the healthcare industry increasingly shifts..

Bioventus Inc. (BVS) Stock Report: Navigating the 84% Potential Upside in Medical Devices

Bioventus Inc. (NASDAQ: BVS) stands out in the healthcare sector’s medical devices industry with its innovative solutions for pain relief and musculoskeletal therapies. Headquartered in Durham, North Carolina, Bioventus has..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth in the Healthcare Sector

Sonida Senior Living, Inc. (NYSE: SNDA), a key player in the healthcare sector, stands out as a significant entity within the medical care facilities industry. Based in Dallas, Texas, Sonida..

Upstream Bio, Inc. (UPB) Stock Analysis: Potential 49.64% Upside Amid Strong Buy Ratings

Investors seeking opportunities in the biotechnology sector may find Upstream Bio, Inc. (UPB) an intriguing prospect. As a clinical-stage biotech company, Upstream Bio focuses on the development of treatments for..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a Potential 28% Upside in the Cannabis Sector

Tilray Brands, Inc. (NASDAQ: TLRY), a key player in the global cannabis industry, presents a unique investment opportunity with its expansive portfolio and international reach. With a market capitalization of..

Ardelyx, Inc. (ARDX) Stock Analysis: Unpacking a 70% Potential Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotech company listed on the NASDAQ exchange, is making waves in the healthcare sector with its innovative approach to addressing unmet medical needs. The company,..

uniQure N.V. (QURE) Stock Analysis: Uncovering a 143.91% Potential Upside in the Biotech Sector

uniQure N.V. (NASDAQ: QURE) is a shining beacon in the biotechnology industry, captivating investors with its innovative approach to treating rare and devastating diseases. Based in the Netherlands, this healthcare..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Strong Buy Ratings Amid Potential 7% Upside

Maze Therapeutics, Inc. (MAZE), a burgeoning player in the biotechnology sector, is captivating investor attention with its robust pipeline of precision medicines targeting renal and cardiovascular diseases, alongside metabolic disorders..

Arvinas, Inc. (ARVN) Stock Analysis: Navigating the Biotech Frontier with Potential Upside

Arvinas, Inc. (NASDAQ: ARVN) is a clinical-stage biotechnology company that has carved a niche in the healthcare sector by focusing on innovative protein degradation therapies. Headquartered in New Haven, Connecticut,..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth Challenges with Strategic Collaborations

Personalis, Inc. (NASDAQ: PSNL), a key player in the healthcare sector’s diagnostics and research industry, is at a critical juncture. With a market capitalization just shy of $1 billion, this..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Promising 315% Potential Upside in Biotechnology

Investors with a keen eye on the biotechnology sector may find Anavex Life Sciences Corp. (NASDAQ: AVXL) an intriguing prospect. Positioned in the healthcare industry, Anavex is making significant strides..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 46% Potential Upside for Investors

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a dynamic player in the biotechnology sector, is capturing investor attention with its compelling 46.42% potential upside, as suggested by current analyst ratings. Headquartered..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A Biotech with 90% Upside Potential

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) is making waves in the biotechnology sector with a compelling growth narrative. As a commercial-stage company, Day One is dedicated to developing innovative treatments..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating the -3.73% Potential Downside in a Competitive Medical Device Landscape

Investors with an eye on the healthcare sector, particularly those focused on medical devices, might find Standard BioTools Inc. (NASDAQ: LAB) an intriguing subject of analysis. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds